Woodline Partners LP Apellis Pharmaceuticals, Inc. Transaction History

Woodline Partners LP

$11 Billion
Q3 2024

A detailed history of Woodline Partners LP transactions in Apellis Pharmaceuticals, Inc. stock. As of the latest transaction made, Woodline Partners LP holds 188,564 shares of APLS stock, worth $6.25 Million. This represents 0.05% of its overall portfolio holdings.

Number of Shares

188,564

Previous 187,000 0.84%

Holding current value

$6.25 Million

Previous $7.17 Million 24.19%

% of portfolio

0.05%

Previous 0.07%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$28.84 - $41.15 $45,105 - $64,358	1,564 Added 0.84%	188,564 $5.44 Million
Q2 2024 Aug 14, 2024	BUY	$38.07 - $59.71 $76 - $119	2 Added 0.0%	187,000 $7.17 Million
Q1 2024 May 15, 2024	BUY	$55.39 - $72.47 $42,871 - $56,091	774 Added 0.42%	186,998 $11 Million
Q4 2023 Feb 14, 2024	BUY	$37.14 - $64.82 $6.92 Million - $12.1 Million	186,224 New	186,224 $11.1 Million
Q4 2022 Feb 14, 2023	BUY	$43.24 - $61.04 $3.05 Million - $4.31 Million	70,651 New	70,651 $3.65 Million
Q1 2022 May 16, 2022	SELL	$35.46 - $54.12 $1.46 Million - $2.23 Million	-41,199 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$30.74 - $49.16 $2.06 Million - $3.29 Million	-66,877 Reduced 61.88%	41,199 $1.95 Million
Q3 2021 Nov 15, 2021	BUY	$31.4 - $69.84 $3.39 Million - $7.55 Million	108,076 New	108,076 $3.56 Million
Q2 2021 Aug 16, 2021	SELL	$40.9 - $64.9 $7.01 Million - $11.1 Million	-171,419 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$40.8 - $57.39 $6.99 Million - $9.84 Million	171,419 New	171,419 $7.36 Million
Q2 2020 Aug 14, 2020	SELL	$24.8 - $38.49 $5.58 Million - $8.66 Million	-224,948 Closed	0 $0
Q1 2020 May 15, 2020	BUY	$17.91 - $44.33 $1.65 Million - $4.08 Million	92,001 Added 69.2%	224,948 $6.03 Million
Q4 2019 Feb 14, 2020	BUY	$22.1 - $30.8 $2.94 Million - $4.09 Million	132,947 New	132,947 $4.07 Million

Others Institutions Holding APLS

# of Institutions

308

Shares Held

115M

Call Options Held

3.85M

Put Options Held

1.09M

View Full List

About Apellis Pharmaceuticals, Inc.

Ticker APLS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 109,865,000
Market Cap $3.64B
Description
Apellis Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of therapeutic compounds through the inhibition of the complement system for autoimmune and inflammatory diseases. The company's lead product candidate is pegcetacoplan that is in Phase III clinical trials for...

More about APLS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Woodline Partners LP, based on Form 13F filings with the SEC.

News

Stay updated on Woodline Partners LP with notifications on news.

Account

Woodline Partners LP Apellis Pharmaceuticals, Inc. Transaction History